Business Wire

Induced Pluripotent Stem Cell (iPSC) Industry Trends & Forecasts 2025-2030: From Disease Modeling to Cell Therapy - iPSCs Emerge as Cornerstone of Precision Healthcare ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...
Nasdaq

Century Therapeutics to Present Preclinical Data at ASGCT 28th Annual Meeting on Novel iPSC-Derived Cell Therapies for Autoimmune Diseases and Cancer

Century Therapeutics, Inc. announced it will present at the ASGCT 28th Annual Meeting, taking place from May 13-17, 2025, in New Orleans. The company will showcase data related to its preclinical cell ...
Business Wire

Cellino’s iPSC Manufacturing Technology Receives FDA Advanced Manufacturing Technology (AMT) Designation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a leader in advanced biomanufacturing, today announced that its optical biomanufacturing technology for generating induced pluripotent stem cells (iPSCs) ...
Morningstar

XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS

SUZHOU, China, June 2, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell ...
GEN

Cellino, Karis Bio Partner on Autologous iPSC-Based Therapy for Cardiovascular Disease

Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...